Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Investment Group Regulatory News (IIG)

Share Price Information for Intuitive Investment Group (IIG)

Share Price is delayed by 15 minutes
Get Live Data
244.00    4.00 (1.67%)
Bid:
230.00
Ask:
246.00
Spread: 16.00 (6.957%)
Market Cap: £583.91m
IIG Live PriceLast checked at - London Stock Exchange

Intraday Intuitive Investment Group Share Chart

Total Voting Rights

31 May 2023 07:00

RNS Number : 0903B
Intuitive Investments Group plc
31 May 2023
 

31 May 2023

 

Intuitive Investments Group plc

Total Voting Rights

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces that in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company has 74,064,551 ordinary shares of 1 penny each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 74,064,551.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in the interest in, the share capital of the Company.

 

Intuitive Investments Group plc

www.iigplc.com

Julian Baines, Non-Executive Chairman

Robert Naylor, CEO

Via Turner Pope Investments (TPI) Ltd

 

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0)20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0)20 3657 0050

Andrew Thacker / James Pope

 

 

About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide investors withexposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businessesoperating predominantly in the UK, continental Europe and the US, utilising the Board's experienceand in particular that of the Chairman of the Investment Committee, David Evans, to seek togenerate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAESEDFXDEAA
Date   Source Headline
15th Oct 20218:01 amRNSLight Science Technologies Holdings - Floatation
12th Oct 20219:48 amRNSLight Science Technologies - Intention To Float
20th Sep 20218:04 amRNSLight Science Technologies Holdings - update
15th Sep 20217:00 amRNSInvestment in Momentum Bioscience Limited
20th Aug 20213:40 pmRNSDirector Dealing
29th Jun 202110:56 amRNSInvestment in Midatech Pharma PLC
2nd Jun 20217:00 amRNSInterim report
28th May 20212:18 pmRNSInvestment in Trellus Health plc
4th May 20217:00 amRNSInvestment in The Electrospinning Company Limited
9th Apr 202111:01 amRNSIssue of Shares and Total Voting Rights
1st Apr 20217:00 amRNSInvestment in Axol Bioscience Ltd
31st Mar 20214:18 pmRNSInvestment in Altair
31st Mar 202112:00 pmRNSInvestment in CardiNor AS
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20217:00 amRNSInvestment in Micrima Limited
1st Mar 20217:00 amRNSInvestment in Shield Therapeutics plc
22nd Feb 20217:00 amRNSInvestment in Yourgene Health plc
12th Feb 202111:41 amRNSProposed Investment in Kromek Pharma plc
8th Feb 202111:08 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSProposed Investment in Evgen Pharma plc
29th Jan 20217:00 amRNSPortfolio company BioQ Pharma receives CE mark
25th Jan 20217:00 amRNSProposed Investment in Microsaic Systems plc
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSInvestment in BioQ Pharma
11th Jan 20217:00 amRNSPre-IPO Investment in Light Science Technologies
14th Dec 20207:00 amRNSAIM Admission & First Day of Dealings
17th Jul 200610:58 amPRNDirector/PDMR Shareholding
30th Jun 200610:19 amPRNIssue of Equity
20th Jun 20063:08 pmPRNDirector/PDMR Shareholding
2nd Jun 200612:20 pmPRNCorrection : Holding(s) in Company
2nd Jun 200612:05 pmPRNHolding(s) in Company
16th May 200610:35 amPRNDirector/PDMR Shareholding
8th May 20062:30 pmPRNAdditional Listing
27th Apr 20061:07 pmPRNDirectorate Change
13th Apr 20069:46 amPRNDirector/PDMR Shareholding
23rd Mar 20064:53 pmPRNAdditional Listing
13th Mar 200610:41 amPRNDirector/PDMR Shareholding
8th Mar 20063:42 pmPRNNotice of Results
22nd Feb 20064:45 pmPRNDirector/PDMR Shareholding
18th Jan 20065:07 pmPRNDirector/PDMR Shareholding
3rd Jan 20068:30 amPRNTrading Statement
21st Dec 20052:54 pmPRNAdditional Listing
20th Dec 200512:16 pmPRNDirector/PDMR Shareholding
20th Dec 200510:51 amPRNAllotment of Shares
12th Oct 20054:18 pmPRNCirc re Interim Results
4th Oct 20052:44 pmPRNAllotment of shares
29th Sep 20059:40 amPRNHolding(s) in Company
29th Sep 20059:35 amPRNDirectorate Change
29th Sep 20056:00 amPRNInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.